本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Mereo Biopharma Group Plc

2.45
+0.05502.30%
成交量:35.34萬
成交額:84.32萬
市值:3.89億
市盈率:-8.36
高:2.46
開:2.40
低:2.29
收:2.39
資料載入中...
2020/06/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/05

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/03/27

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/18

SEC問詢函

CORRESP [Cover] - Correspondence
2020/03/12

[修訂]招股説明書

[Amend] Registration statement for certain foreign private issuers
2020/03/09

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/03/06

SEC問詢函

CORRESP [Cover] - Correspondence
2020/03/06

[修訂]招股説明書

[Amend] Registration statement for certain foreign private issuers
2020/03/02

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/28

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/18

員工持股計劃

Securities to be offered to employees in employee benefit plans
2020/02/18

招股説明書

Registration statement for certain foreign private issuers
2020/02/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/22

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]